`
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________________
`
`MYLAN PHARMACEUTICALS INC.
`Petitioner
`
`v.
`
`BOEHRINGER INGELHEIM INTERNATIONAL GMBH
`Patent Owner.
`
`U.S. Patent No. 8,853,156 to Dugi et al.
`Issue Date: Oct. 7, 2014
`Title: Treatment for Diabetes in Patients
`Inappropriate for Metformin Therapy
`
`
`
`
`
`
`Inter Partes Review No.: IPR2016-01565
`
`
`
`
`
`
`POWER OF ATTORNEY
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.10, Petitioner Mylan Pharmaceuticals Inc.
`
`(“Petitioner”), hereby appoint the following practitioners as its attorneys to transact
`
`all business in the United States Patent & Trademark Office associated with Inter
`
`Partes Review IPR2016-01565 of U.S. Patent No. 8,853,156:
`
`LEAD COUNSEL
`Thomas J. Parker
`Reg. No. 42,062
`thomas.parker@alston.com
`ALSTON & BIRD LLP
`90 Park Avenue, 15th Floor
`New York, NY 10016
`T: (212) 210-9529
`F: (212) 210-9444
`
`
`BACK-UP COUNSEL
`Christopher L. McArdle
`(pro hac vice motion to be filed)
`chris.mcardle@alston.com
`ALSTON & BIRD LLP
`90 Park Avenue, 15th Floor
`New York, NY 10016
`T: (212) 210-9542
`F: (212) 922-3843
`Ellen Y. Cheong (Reg. No. 71,852)
`ellen.cheong@alston.com
`ALSTON & BIRD LLP
`90 Park Avenue, 15th Floor
`New York, NY 10016
`T: (212) 210-1277
`F: (212) 210-9444
`Charles A. Naggar
`(pro hac vice motion to be filed)
`charles.naggar@alston.com
`ALSTON & BIRD LLP
`90 Park Avenue, 15th Floor
`New York, NY 10016
`T: (212) 210-1275
`F: (212) 210-9444
`
`
`
`
`
`
`
`
`
`1
`
`
`
`Petitioner Mylan Pharmaceuticals Inc.
`K‘?
`
`BY:
`NAME:
`
`[NM \,~3‘ é-l—]["wi
`'"
`.
`Z"
`owx 90.
`A2~~‘Cw\§'
`
`(‘7“a!25'»‘
`(,vL-
`TITLE: [§§e’f.
`DATE:
`3, l 4| 2 Mo
`
`ll’ L«L<e3a¥*.9,_\
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on August 10, 2016, a copy of this Power of Attorney
`
`was served via U.S.P.S. Priority Mail Express, on Boehringer Ingelheim USA
`
`Corporation at the correspondence address of record for the 8,853,156 patent as
`
`evidenced in Public PAIR on August 10, 2016, namely
`
`Michael P. Morris
`Boehringer Ingelheim USA Corporation
`900 Ridgebury Road
`P. O. Box 368
`Ridgefield, CT 06877- 0368
`
`/Thomas J. Parker/
`Telephone: (212) 210-9529
`Facsimile: (212) 210-9444
`
`
`
`Dated: August 10, 2016
`
`
`
`3